Every earnings call for INNOVACAP — management tone, guidance, KPIs and promise tracking, quarter by quarter.
INNOVACAP · 6 transcripts · Healthcare · latest Q4 FY26Innova Captab Limited has 6 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue (Q4 FY26) ₹448 cr (+42% YoY); EBITDA (Q4 FY26) ₹67 cr (+31% YoY); EBITDA Margin (Q4 FY26) 14.9%. Consolidated revenue grew 42% YoY in Q4 FY26 to ₹447.8 crores.
Read full transcript & analysisRevenue ₹450 cr (+42% YoY); EBITDA ₹71 cr (+40% YoY); EBITDA Margin 15.8%. Revenue from operations surged to ₹450.3 crores in Q3 FY26, marking a robust 42.3% year-on-year growth.
Read full transcript & analysisRevenue ₹380 cr (+20% YoY); EBITDA ₹56 cr (+8% YoY); EBITDA Margin 14.7%. Consolidated revenue grew 19.5% YoY to INR380.4 crores in Q2 FY26 and INR731.9 crores in H1 FY26.
Read full transcript & analysisRevenue ₹352 cr (+19% YoY); EBITDA ₹57 cr (+28% YoY); EBITDA Margin 16.1%. Consolidated revenue of ₹351.5 crores, up 19% YoY.
Read full transcript & analysisFY25 Revenue ₹1,244 cr (+15% YoY); FY25 EBITDA ₹198 cr (+19% YoY); FY25 EBITDA Margin 15.9% (+0% YoY). FY25 Total Revenue: INR1,243.7 crores, up 15% YoY.
Read full transcript & analysisRevenue ₹316 cr (+5% YoY); EBITDA Margin 16.1%; PAT ₹34 cr (+36% YoY). Q3 FY25 consolidated revenue stood at ₹316.5 crores, registering a year-on-year growth of almost 5%.
Read full transcript & analysis